|
SEC22A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.706400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.107000E-01 |
| Normal-vs-Stage2 |
3.608800E-01 |
| Normal-vs-Stage3 |
8.637200E-01 |
| Normal-vs-Stage4 |
9.179000E-01 |
| Stage1-vs-Stage2 |
1.514560E-01 |
| Stage1-vs-Stage3 |
5.027000E-01 |
| Stage1-vs-Stage4 |
6.036600E-01 |
| Stage2-vs-Stage3 |
4.359800E-01 |
| Stage2-vs-Stage4 |
4.057600E-01 |
| Stage3-vs-Stage4 |
9.433600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.665000E-01 |
| Normal-vs-AfricanAmerican |
2.567800E-01 |
| Normal-vs-Asian |
9.376200E-01 |
| Caucasian-vs-AfricanAmerican |
1.321030E-01 |
| Caucasian-vs-Asian |
9.545400E-01 |
| AfricanAmerican-vs-Asian |
5.126600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.701600E-01 |
| Normal-vs-Female |
2.008200E-01 |
| Male-vs-Female |
4.398100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.371600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.132400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.664600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.188210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.848200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.897400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.482200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.325900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.850500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.109400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.363500E-02 |
| Normal-vs-Grade 2 |
3.548000E-01 |
| Normal-vs-Grade 3 |
4.319000E-01 |
| Normal-vs-Grade 4 |
1.979570E-01 |
| Grade 1-vs-Grade 2 |
2.041400E-01 |
| Grade 1-vs-Grade 3 |
2.493600E-02 |
| Grade 1-vs-Grade 4 |
1.764340E-02 |
| Grade 2-vs-Grade 3 |
1.733810E-02 |
| Grade 2-vs-Grade 4 |
1.525720E-02 |
| Grade 3-vs-Grade 4 |
4.230800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.227620E-01 |
| Normal-vs-ccB subtype |
4.216000E-01 |
| ccA subtype-vs-ccB subtype |
2.381800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.406600E-01 |
| Normal-vs-N1 |
4.982200E-01 |
| N0-vs-N1 |
6.660400E-01 |
|
|
